Investor Presentaiton
Krunal Shah
Company Secretary
+91 22 4111 4779
[email protected]
For details, feel free to contact:
Abhishek Singhal
Investor Relations Consultant
[email protected]
J Sequent
Proven Ability In Life Sciences
ALIVIRA
Nachiket Kale
Investor Relations Advisor
+91 9920940808
[email protected]
Registered Office: 301/A, 'Dosti Pinnacle', Plot No. E7, Road No. 22, Wagle Industrial Area, Thane (W), Maharashtra, India
Websites: www.sequent.in, www.alivira.co | CIN: L99999MH1985PLC036685 | BSE Code: 512529 | NSE: SEQUENT | ISIN:
INE807F01027
Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like
government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated
by the relevant forward-looking statements. SeQuent Scientific Ltd. will not be in any way responsible for any action taken based on such statements and undertakes no obligation to
publicly update these forward-looking statements to reflect subsequent events or circumstances.
12View entire presentation